These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27412556)

  • 1. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
    Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
    Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
    Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
    Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SREBP1c-CRY1 axis suppresses hepatic gluconeogenesis upon insulin.
    Jang H; Lee G; Kim JB
    Cell Cycle; 2017 Jan; 16(2):139-140. PubMed ID: 27651077
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic GSK3β-Dependent CRY1 Degradation Contributes to Diabetic Hyperglycemia.
    Kim YY; Jang H; Lee G; Jeon YG; Sohn JH; Han JS; Lee WT; Park J; Huh JY; Nahmgoong H; Han SM; Kim J; Pak M; Kim S; Kim JS; Kim JB
    Diabetes; 2022 Jul; 71(7):1373-1387. PubMed ID: 35476750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
    Goyal N; Tiwary S; Kesharwani D; Datta M
    J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring finger protein20 regulates hepatic lipid metabolism through protein kinase A-dependent sterol regulatory element binding protein1c degradation.
    Lee JH; Lee GY; Jang H; Choe SS; Koo SH; Kim JB
    Hepatology; 2014 Sep; 60(3):844-57. PubMed ID: 24425205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin F
    Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
    Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
    Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
    Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor.
    Kamei Y; Miura S; Suganami T; Akaike F; Kanai S; Sugita S; Katsumata A; Aburatani H; Unterman TG; Ezaki O; Ogawa Y
    Endocrinology; 2008 May; 149(5):2293-305. PubMed ID: 18202130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
    Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
    J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
    Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
    J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
    J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
    Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic enyzymes and thereby aiding glycemic control.
    McCarty MF
    Med Hypotheses; 2016 Oct; 95():45-48. PubMed ID: 27692165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy.
    Hall JA; Tabata M; Rodgers JT; Puigserver P
    Mol Endocrinol; 2014 Jun; 28(6):912-24. PubMed ID: 24694308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.